Friday, October 16, 2020 11:58:01 AM
The P-Value determines the possibility that the results we are seeing are wrong. The stronger the P-value, the less chance our results are a mistake. A P-Value of P<=0.0001 would be sooooo strong, that it would be unethical to continue trials. In other words, if you are THAT CERTAIN the drug works, then stop the trial and quick giving the dying patients a placebo, because they will continue to die at a high rate, so we need to stop and actually give them RLF100.
You asked: "Why NOT finish recruitment and collect firmer data?"
Because trial placebo will continue to let people die.
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM